Clementia Pharmaceuticals Inc (CMTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||
| Net Income | -7,511 | -6,064 | -75,890 |
| Depreciation Amortization | 86 | 43 | 140 |
| Other Working Capital | -1,280 | -1,032 | 2,060 |
| Other Operating Activity | -1,251 | 1,408 | 56,070 |
| Operating Cash Flow | $-9,955 | $-5,645 | $-17,620 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -40,000 | -40,000 | N/A |
| PPE Investments | -20 | -20 | -40 |
| Other Investing Activity | 31 | 13 | -20 |
| Investing Cash Flow | $-39,989 | $-40,006 | $-60 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 0 | 0 | 70,670 |
| Financing Cash Flow | $N/A | $N/A | $70,670 |
| Exchange Rate Effect | 136 | 134 | -380 |
| Beginning Cash Position | 58,107 | 58,107 | 5,500 |
| End Cash Position | 8,298 | 12,590 | 58,100 |
| Net Cash Flow | $-49,809 | $-45,517 | $52,600 |
| Free Cash Flow | |||
| Operating Cash Flow | -9,955 | -5,645 | -17,620 |
| Capital Expenditure | -20 | -20 | N/A |
| Free Cash Flow | -9,975 | -5,665 | -17,620 |